Vermersch P - Search Results

1

Long-term effect of natalizumab in patients with RRMS: TYSTEN cohort.

Bigaut K, Fabacher T, Kremer L, Ongagna JC, Kwiatkowski A, Sellal F, Ferriby D, Courtois S, Vermersch P, Collongues N, Zéphir H, De Seze J, Outteryck O. Bigaut K, et al. Among authors: vermersch p. Mult Scler. 2021 Apr;27(5):729-741. doi: 10.1177/1352458520936239. Epub 2020 Jul 9. Mult Scler. 2021. PMID: 32643521

2

14-3-3 Protein in the cerebrospinal fluid of patients with acute transverse myelitis and multiple sclerosis.

de Seze J, Peoc'h K, Ferriby D, Stojkovic T, Laplanche JL, Vermersch P. de Seze J, et al. Among authors: vermersch p. J Neurol. 2002 May;249(5):626-7. doi: 10.1007/s004150200074. J Neurol. 2002. PMID: 12021955 No abstract available.

3

Phrenic nerve palsy as a feature of chronic inflammatory demyelinating polyradiculoneuropathy.

Stojkovic T, De Seze J, Hurtevent JF, Fourrier F, Vermersch P. Stojkovic T, et al. Among authors: vermersch p. Muscle Nerve. 2003 Apr;27(4):497-9. doi: 10.1002/mus.10361. Muscle Nerve. 2003. PMID: 12661053

4

Multiple sclerosis and depression: influence of interferon beta therapy.

Zephir H, De Seze J, Stojkovic T, Delisse B, Ferriby D, Cabaret M, Vermersch P. Zephir H, et al. Among authors: vermersch p. Mult Scler. 2003 Jun;9(3):284-8. doi: 10.1191/1352458503ms915oa. Mult Scler. 2003. PMID: 12814176

5

Distortion of the self-reactive IgG antibody repertoire in multiple sclerosis as a new diagnostic tool.

Lefranc D, Almeras L, Dubucquoi S, de Seze J, Vermersch P, Prin L. Lefranc D, et al. Among authors: vermersch p. J Immunol. 2004 Jan 1;172(1):669-78. doi: 10.4049/jimmunol.172.1.669. J Immunol. 2004. PMID: 14688380

6

Autoantibodies against alpha-fodrin in Sjögren's syndrome with neurological manifestations.

de Seze J, Dubucquoi S, Fauchais AL, Hachulla E, Matthias T, Lefranc D, Hatron PY, Vermersch P, Witte T. de Seze J, et al. Among authors: vermersch p. J Rheumatol. 2004 Mar;31(3):500-3. J Rheumatol. 2004. PMID: 14994394

7

New antigenic candidates in multiple sclerosis: identification by serological proteome analysis.

Almeras L, Lefranc D, Drobecq H, de Seze J, Dubucquoi S, Vermersch P, Prin L. Almeras L, et al. Among authors: vermersch p. Proteomics. 2004 Jul;4(7):2184-94. doi: 10.1002/pmic.200300732. Proteomics. 2004. PMID: 15221778

8

Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients.

Delalande S, de Seze J, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, Dubucquoi S, Pruvo JP, Vermersch P, Hatron PY. Delalande S, et al. Among authors: vermersch p. Medicine (Baltimore). 2004 Sep;83(5):280-291. doi: 10.1097/01.md.0000141099.53742.16. Medicine (Baltimore). 2004. PMID: 15342972 Free article.

9

New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis.

El Behi M, Dubucquoi S, Lefranc D, Zéphir H, De Seze J, Vermersch P, Prin L. El Behi M, et al. Among authors: vermersch p. Immunol Lett. 2005 Jan 15;96(1):11-26. doi: 10.1016/j.imlet.2004.07.017. Immunol Lett. 2005. PMID: 15585303 Review.

10

Myelopathies secondary to Sjögren's syndrome: treatment with monthly intravenous cyclophosphamide associated with corticosteroids.

de Seze J, Delalande S, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, Hatron PY, Vermersch P. de Seze J, et al. Among authors: vermersch p. J Rheumatol. 2006 Apr;33(4):709-11. J Rheumatol. 2006. PMID: 16583474

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

500 results

Search Page

Filters